Sanyou Biopharmaceuticals is contract research organization company focused on R&D and services to create innovative antibody drugs.
Sanyou Biopharmaceuticals Co., Ltd. is a leading international CRO (contract research organization) company focused on R&D and services to create innovative antibody drugs. The company has established an integrated innovative antibody drug R&D laboratory of several thousand square meters with advanced facilities in Caohejing Hi-Tech Park. During the last five years, Sanyou built and validated more than 20 core technological platforms such as: innovative antibody drug discovery, antibody engineering, in vivo and in vitro drug efficacy evaluation, stable cell line construction, and production process development.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 2, 2022 | Series B | — | 1 | — | — | Detail |
Jun 25, 2021 | Series B | — | 2 | Qianhai LH Ventures | — | Detail |
May 16, 2020 | Series A | — | 2 | Shanghai ZJ Bio-Tech Technology Haier Financial Holdings | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Shanghai ZJ Bio-Tech Technology | Yes | Series A |
Haier Financial Holdings | Yes | Series A |
Qianhai LH Ventures | — | Series B |
Seeking Capital | — | Series B |